MassChallenge
MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, established in 2009. It supports early-stage entrepreneurs across various industries, including technology, healthcare, and social impact, by providing mentorship, resources, and networking opportunities. With locations in Israel, Mexico, Switzerland, Texas, and the UK, MassChallenge connects high-potential startups with industry experts and investors to foster innovation and facilitate growth. The accelerator operates on a non-equity model, allowing entrepreneurs to maintain full ownership of their companies while benefiting from strategic partnerships and tailored training programs. Through its diverse initiatives, such as targeted accelerator programs like MassChallenge HealthTech and FinTech, the organization aims to drive impactful change and enhance the global innovation ecosystem.
Tru-Spot
Non Equity Assistance in 2021
Tru-Spot Technologies is an augmented reality company based in Brandon, Mississippi, focused on enhancing live event experiences for fans at concerts and sporting events. The company is developing innovative interactive features that allow users to engage with real-time events from home while utilizing on-field body camera technology. This technology aims to provide a more immersive experience that goes beyond traditional live streaming, giving customers greater control over their viewing experience. In addition to enhancing entertainment, Tru-Spot's adaptive body camera technology is also designed to assist victims of mass shootings, unjust arrests, and other crimes. To finalize the development of its augmented reality app and launch a proof of concept, Tru-Spot is seeking $150,000 in seed capital.
Sano Chemicals
Non Equity Assistance in 2020
Sano Chemicals is an early-stage biotechnology company focused on developing innovative anti-infectives for both clinical and agricultural applications. The company aims to enhance health and promote a sustainable environment through its unique products. Sano Chemicals specializes in antifungal treatments, particularly targeting fungal infections in humans as well as bio-control methods for crops. One of their key compounds, occidiofungin, is a novel antifungal discovered by researchers at Mississippi State University and Texas A&M University. The company is working on various applications of occidiofungin to address fungal infections affecting nails, skin, and systemic health, while also developing solutions to combat fungal diseases in plants. Through these efforts, Sano Chemicals seeks to revolutionize the antifungal industry and improve quality of life for patients and sustainable agricultural practices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.